Federal grants to Syntrix Biosystems Inc.
Syntrix Biosystems Inc. in Auburn, Washington received $3.8 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cancer Treatment Research, with $3.7 million. In fiscal 2025 it was awarded $1.5 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.8 million
- Awards4
- Awarded in FY 2025$1.5 million
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $731,545 |
| FY 2022 | 0 | -$6,220 |
| FY 2023 | 1 | $400,000 |
| FY 2024 | 2 | $1.1 million |
| FY 2025 | 2 | $1.5 million |
Programs that fund Syntrix Biosystems Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $3.7 million |
| Drug Use and Addiction Research Programs | 1 | $80,191 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A phase 2, single-arm study of the CXCR1/2 inhibitor SX-682 plus enzalutamide in men with abiraterone-resistant metastatic castration resistant prostate cancer (MCRPC) - prostate cancer (PC) is the second leading cause of cancer-related death among american men, and the vast majority of these deaths | Cancer Treatment Research | July 7, 2023 | $2.0 million |
| A dose expansion study of SX-682 alone and in combination with decitabine in mds patients - myelodysplastic syndromes (MDS) are genetically and morphologically diverse hematopoietic neoplasms that arise from a small pool of mutant clones within hematopoietic stem and progenitor compartments [1-9]. M | Cancer Treatment Research | September 16, 2024 | $1.0 million |
| A phase 1 clinical trial evaluating the novel small molecule immuno-oncology antagonist SX-682 alone and with pembrolizumab in metastatic melanoma | Cancer Treatment Research | August 9, 2021 | $651,354 |
| A phase 1 randomized single oral dose four period cross-over study investigating omnitram dose proportionality and food effect in normal human subjects | Drug Use and Addiction Research Programs | February 18, 2021 | $80,191 |
Questions people ask
How much federal grant money does Syntrix Biosystems Inc. get?
$3.8 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Syntrix Biosystems Inc. the most?
The Department of Health and Human Services, with $3.8 million in 4 awards.
What is Syntrix Biosystems Inc.'s largest federal grant?
$2.0 million under Cancer Treatment Research, with its first action in the period on July 7, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Syntrix Biosystems Inc.?
Its largest are Cancer Treatment Research and Drug Use and Addiction Research Programs.
Other grant recipients in Auburn
- World Vision Inc.
- Muckleshoot Indian Tribe
- Green River College
- Muckleshoot Housing Auth
- City of Auburn
- New Roots Fund
- Forest Concepts LLC
- Auburn School District
Largest federal grant recipients in Washington · Federal grants in Washington